Arrowhead Research reported $44.37M in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -94.77M 3.81M
Alnylam Pharmaceuticals ALNY:US $ -239.36M 20.95M
Anika Therapeutics ANIK:US $ -3.71M 5.46M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Bluebird Bio BLUE:US $ -122.15M 10.09M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
IONIS PHARMACEUT IONS:US $ -64M 289M
Merk MRK:US $ 6309M 1525M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Moderna Inc MRNA:US 4.23B 1.18B
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Novartis NOVN:VX SF 3912M 230M
Opko Health OPK:US $ -76.65M 10.85M
Sarepta Therapeutics SRPT:US $ -104.15M 17.74M
Tg Therapeutics TGTX:US $ -69.01M 24.32M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M
Xencor XNCR:US $ 23.59M 49.47M
YTE INCY:US $ 172.84M 1.75M